Results 151 to 160 of about 158,916 (259)
G‐CSF for Mobilizing CD34+ Cells in Individuals With SCD: A Word of Caution
American Journal of Hematology, Volume 101, Issue 6, Page 1178-1181, June 2026.
Akshay Sharma +17 more
wiley +1 more source
Abstract There are currently no approved pharmacotherapies to treat cognitive impairment associated with schizophrenia (CIAS). Iclepertin (BI 425809) is a selective glycine transporter‐1 (GlyT1) inhibitor that was investigated for the treatment of CIAS.
Peter Nagy +9 more
wiley +1 more source
Liver Fibrosis: Molecular Pathogenesis and Therapeutic Interventions
We systematically summarized the etiologies, diagnostic approaches, and pathogenic mechanisms of liver fibrosis. Also, the therapeutic interventions for liver fibrosis were systematically classified into two main categories: etiological treatment and mechanism‐based antifibrotic therapies.
Jiaorong Qu +8 more
wiley +1 more source
Maternal Coagulation Profiles in Pregnant Women with Thalassemia: A Retrospective Observational Study in South China. [PDF]
Dong C, Chen X, Zhang L, Zhou H, Lin M.
europepmc +1 more source
Abstract Carrier screening for genetic conditions performed preconception or during pregnancy allows identification of fetal risk for inherited autosomal recessive and X‐linked conditions. The goal is to identify at‐risk patients/couples and offer them reproductive options such as preimplantation genetic diagnosis, prenatal testing, or targeted newborn
Emily B. Rosenfeld +5 more
wiley +1 more source
Endocrine complications in transfusion-dependent β-thalassemia – A single center experience
Binita Poudel +10 more
doaj +1 more source
Common hemoglobin variants affecting the diagnosis of β-thalassemia: A large cohort data at a single center. [PDF]
Singha K +8 more
europepmc +1 more source
Clinical value of miR-329-3p in thalassemia and its regulation of TNRC6B expression. [PDF]
Zhao Y, Gao J, Li Y, Li S, Li W, Cen M.
europepmc +1 more source
Whole Blood Transcriptomic Analysis of Sickle Cell Trait
ABSTRACT Sickle cell trait (SCT) is the heterozygous carrier state for the HBB missense variant which causes sickle cell disease (SCD). SCT has been associated with increased risk of venous thromboembolism and chronic kidney disease as well as alterations in clinical laboratory parameters. To investigate differential gene expression in SCT, we used RNA
Mari Johnson +12 more
wiley +1 more source
A case report of congenital sideroblastic anemia caused by a novel ALAS2 mutation in conjunction with thalassemia. [PDF]
Chen ZX +6 more
europepmc +1 more source

